- Report
- October 2024
- 138 Pages
Global
From €2206EUR$2,500USD£1,931GBP
- Report
- December 2023
- 165 Pages
Global
From €2206EUR$2,500USD£1,931GBP
- Report
- February 2020
- 120 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- July 2025
- 200 Pages
Australia
From €2197EUR$2,490USD£1,924GBP
- Report
- January 2023
- 50 Pages
China
From €2647EUR$3,000USD£2,318GBP
- Report
- September 2021
- 40 Pages
China
From €2294EUR$2,600USD£2,009GBP
From €2294EUR$2,600USD£2,009GBP
From €2294EUR$2,600USD£2,009GBP
- Report
- June 2021
- 50 Pages
China
From €2294EUR$2,600USD£2,009GBP
- Report
- May 2021
- 50 Pages
China
From €2294EUR$2,600USD£2,009GBP
- Report
- April 2021
China
From €2294EUR$2,600USD£2,009GBP
- Report
- December 2018
- 30 Pages
China
From €1941EUR$2,200USD£1,700GBP
- Report
- November 2023
- 135 Pages
Global
From €3529EUR$4,000USD£3,090GBP
- Report
- October 2024
- 203 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- October 2024
- 170 Pages +
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- July 2024
- 100 Pages
Global
From €2647EUR$3,000USD£2,318GBP
€3308EUR$3,750USD£2,897GBP
- Report
- June 2024
- 200 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- June 2024
- 200 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- June 2024
- 200 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP
- Report
- June 2024
- 200 Pages
Global
From €5611EUR$6,360USD£4,913GBP
€7014EUR$7,950USD£6,142GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more